Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Oncoimmunology
Shakeel ModakKatharine Hsu

Abstract

Natural killer (NK) cell-mediated antibody-dependent toxicity is a potent mechanism of action of the anti-GD2 murine monoclonal antibody 3F8 (m3F8). Killer immunoglobulin-like receptor (KIR) and HLA genotypes modulate NK activity and are key prognostic markers in m3F8-treated patients with neuroblastoma. Endogenous NK-cells are suppressed in the setting of high tumor burden and chemotherapy. Allogeneic NK-cells however, demonstrate potent anti-neuroblastoma activity. We report on the results of a phase I clinical trial of haploidentical NK-cells plus m3F8 administered to patients with high-risk neuroblastoma after conditioning chemotherapy. The primary objective was to determine the maximum tolerated NK-cell dose (MTD). Secondary objectives included assessing anti-neuroblastoma activity and its relationship to donor-recipient KIR/HLA genotypes, NK function, and donor NK chimerism. Patients received a lymphodepleting regimen prior to infusion of haploidentical CD3-CD56+ NK-cells, followed by m3F8. Overall and progression free survival (PFS) were assessed from the time of first NK-cell dose. Univariate Cox regression assessed relationship between dose and outcomes. Thirty-five patients received NK-cells at one of five dose levels...Continue Reading

References

Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M BrodeurF Hedborg
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katharine C HsuBo Dupont
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian H KushnerNai-Kong V Cheung
Mar 30, 2004·European Journal of Immunology·Pascale AndréPascale Paul
Nov 22, 2005·Biochemical and Biophysical Research Communications·Henry OgbomoJindrich Cinatl
Aug 12, 2006·Immunity·Nicolas AnfossiEric Vivier
Nov 15, 2006·Immunological Reviews·Wayne M Yokoyama, Sungjin Kim
Jun 26, 2007·Lancet·John M MarisSusan L Cohn
Oct 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Junli YuKatharine C Hsu
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey M VenstromKatharine C Hsu
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey E RubnitzWing Leung
Oct 1, 2010·The New England Journal of Medicine·Alice L YuUNKNOWN Children's Oncology Group
Dec 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene Y CheungNai-Kong V Cheung
Aug 7, 2012·The Journal of Clinical Investigation·Nidale TarekKatharine C Hsu
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nai-Kong V CheungShakeel Modak
Nov 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin C ConlonThomas A Waldmann
Jan 22, 2015·Expert Opinion on Therapeutic Targets·Maya Suzuki, Nai-Kong V Cheung
Sep 23, 2016·Science Translational Medicine·Rizwan RomeeTodd A Fehniger
Feb 27, 2017·Current Opinion in Immunology·Aura MuntasellIgnacio Melero
Sep 25, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sara M FedericoWayne L Furman
Oct 4, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy K ErbePaul M Sondel

❮ Previous
Next ❯

Citations

Nov 28, 2018·Current Opinion in Pediatrics·Suzanne MacFarland, Rochelle Bagatell
May 17, 2019·Immunotherapy·Parnian JabbariNima Rezaei
Oct 17, 2019·Cancers·Sooyeon OhSang-Woon Choi
Aug 24, 2019·Pediatric Hematology and Oncology·Hema DaveCatherine M Bollard
Feb 28, 2020·Cancers·Celina L SzantoStefan Nierkens
Jan 11, 2020·Frontiers in Immunology·Karen Slattery, Clair M Gardiner
Jun 18, 2020·Stem Cell Research & Therapy·Keerthana ShankarKrishanu Saha
Mar 11, 2020·Frontiers in Immunology·Aviad Ben-ShmuelMira Barda-Saad
Sep 11, 2019·Current Oncology Reports·Miriam Santiago KimpoShawn Lee
May 28, 2020·Frontiers in Immunology·Kevin O McNerneyHamid Bassiri
Jun 12, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soo-Chin LeeDario Campana
Jan 17, 2021·Vaccines·Fabio MorandiIrma Airoldi
Jun 18, 2021·Biologics : Targets & Therapy·Wayne L Furman
Nov 26, 2021·Paediatric Drugs·Ajay Gupta, Timothy P Cripe

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
leukapheresis
biopsies
PCR
flow cytometry

Clinical Trials Mentioned

NCT00877110
NCT02650648

Software Mentioned

SAS

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.